Hint mode is switched on Switch off

Fagron, ordinary share
FAGR, BE0003874915

Add a stock to WL
Choose all Reset all
Fagron, сountry — Belgium
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Fagron NV, formerly Arseus NV, is a Belgium-based company that provides products and services for professionals and institutions active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier. The ...
Fagron NV, formerly Arseus NV, is a Belgium-based company that provides products and services for professionals and institutions active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier. The Company is active in two divisions: Fagron, which supplies pharmaceutical raw materials, equipment and supplies, concepts, and pharmaceutical compounding to pharmacies and hospital pharmacies in over 30 countries; and HL Technology, which develops and produces precision components and orthopedic tools for dental and medical professionals. The Company is active in around 30 countries in Europe, the Americas, the Middle East, Africa, Asia and the Pacific.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Fagron NV
  • Industry
    Pharmaceutical Preparation and Biotechnology

Indicators

News

07/01/2025 Fagron to Buy US-based CareFirst Specialty Pharmacy, Brazil's Injeplast
15/09/2024 Fagron Completes Share Repurchase Program
All organization news

Holders

Industry Leaders

Registration is required to get access.